Shanghai Hengrui Pharmaceutical Co., Ltd.;Jiangsu Hengrui Medicine Co., Ltd.
发明人:
Gu, Jinming,Luo, Xiao,Tao, Weikang
申请号：
AU2018264455
公开号：
AU2018264455A1
申请日:
2018.05.11
申请国别(地区):
AU
年份:
2019
代理人:
摘要：
Provided are a fusion protein containing a TGF-β receptor and medicinal uses thereof. Also provided are a dual-functional fusion protein comprising a targeted part of a PD-L1 antibody and a TGF-βRII extracellular region, a pharmaceutical composition containing the fusion protein containing the TGF-β receptor, and uses thereof the preparation of anticancer drugs.
